Fresenius Can't Bill Medicare For Overfill, Relator Says

Law360, New York (December 5, 2012, 3:58 PM EST) -- A former Fresenius Medical Care Holdings Inc. technician asked a Georgia federal judge Tuesday for partial judgment in his qui tam False Claims Act suit, saying the company had wrongly claimed that Medicare does not prohibit billing for excess drugs given freely by a drugmaker.

According to Chester Saldivar's motion for partial summary judgment, dialysis center operator Fresenius had incorrectly tried to argue that Medicare Part B providers aren't prohibited from billing for overfill — excess in a drug container above the labeled dose, provided for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.